152 related articles for article (PubMed ID: 23136987)
21. Prognostic factors in patients with non-small cell lung carcinoma and brain metastases: a Malaysian perspective.
Tang WH; Alip A; Saad M; Phua VC; Chandran H; Tan YH; Tan YY; Kua VF; Wahid MI; Tho LM
Asian Pac J Cancer Prev; 2015; 16(5):1901-6. PubMed ID: 25773842
[TBL] [Abstract][Full Text] [Related]
22. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
23. A multi-institutional study of factors influencing the use of stereotactic radiosurgery for brain metastases.
Hodgson DC; Charpentier AM; Cigsar C; Atenafu EG; Ng A; Bahl G; Zadeh G; San Miguel J; Menard C
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):335-40. PubMed ID: 22704984
[TBL] [Abstract][Full Text] [Related]
24. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.
Magnuson WJ; Lester-Coll NH; Wu AJ; Yang TJ; Lockney NA; Gerber NK; Beal K; Amini A; Patil T; Kavanagh BD; Camidge DR; Braunstein SE; Boreta LC; Balasubramanian SK; Ahluwalia MS; Rana NG; Attia A; Gettinger SN; Contessa JN; Yu JB; Chiang VL
J Clin Oncol; 2017 Apr; 35(10):1070-1077. PubMed ID: 28113019
[TBL] [Abstract][Full Text] [Related]
25. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
Samlowski WE; Watson GA; Wang M; Rao G; Klimo P; Boucher K; Shrieve DC; Jensen RL
Cancer; 2007 May; 109(9):1855-62. PubMed ID: 17351953
[TBL] [Abstract][Full Text] [Related]
26. Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous.
Nieder C; Guckenberger M; Gaspar LE; Rusthoven CG; De Ruysscher D; Sahgal A; Nguyen T; Grosu AL; Mehta MP
Radiat Oncol; 2019 Feb; 14(1):33. PubMed ID: 30770745
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic Radiosurgery After Resection of Brain Metastases: Changing Patterns of Care in the United States.
Chin AL; Li G; Gephart MH; Sandhu N; Nagpal S; Soltys SG; Pollom EL
World Neurosurg; 2020 Dec; 144():e797-e806. PubMed ID: 32971279
[TBL] [Abstract][Full Text] [Related]
28. Radiosurgery alone is associated with favorable outcomes for brain metastases from small-cell lung cancer.
Robin TP; Jones BL; Amini A; Koshy M; Gaspar LE; Liu AK; Nath SK; Kavanagh BD; Camidge DR; Rusthoven CG
Lung Cancer; 2018 Jun; 120():88-90. PubMed ID: 29748022
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
30. Relevance of gamma knife radiosurgery alone for the treatment of non-small cell lung cancer brain metastases.
Zairi F; Ouammou Y; Le Rhun E; Aboukais R; Blond S; Vermandel M; Deken V; Devos P; Reyns N
Clin Neurol Neurosurg; 2014 Oct; 125():87-93. PubMed ID: 25108698
[TBL] [Abstract][Full Text] [Related]
31. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
32. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
[TBL] [Abstract][Full Text] [Related]
33. Multi-institutional Nomogram Predicting Survival Free From Salvage Whole Brain Radiation After Radiosurgery in Patients With Brain Metastases.
Gorovets D; Ayala-Peacock D; Tybor DJ; Rava P; Ebner D; Cielo D; Norén G; Wazer DE; Chan M; Hepel JT
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):246-253. PubMed ID: 28068233
[TBL] [Abstract][Full Text] [Related]
34. Gamma knife treatment for multiple metastatic brain tumors compared with whole-brain radiation therapy.
Serizawa T; Iuchi T; Ono J; Saeki N; Osato K; Odaki M; Ushikubo O; Hirai S; Sato M; Matsuda S
J Neurosurg; 2000 Dec; 93 Suppl 3():32-6. PubMed ID: 11143259
[TBL] [Abstract][Full Text] [Related]
35. Differential impact of whole-brain radiotherapy added to radiosurgery for brain metastases.
Kong DS; Lee JI; Im YS; Nam DH; Park K; Kim JH
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):385-9. PubMed ID: 20097485
[TBL] [Abstract][Full Text] [Related]
36. Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer.
Doherty MK; Korpanty GJ; Tomasini P; Alizadeh M; Jao K; Labbé C; Mascaux CM; Martin P; Kamel-Reid S; Tsao MS; Pintilie M; Liu G; Bradbury PA; Feld R; Leighl NB; Chung C; Shepherd FA
Radiother Oncol; 2017 May; 123(2):195-202. PubMed ID: 28363487
[TBL] [Abstract][Full Text] [Related]
37. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
Patil CG; Pricola K; Garg SK; Bryant A; Black KL
Cochrane Database Syst Rev; 2010 Jun; (6):CD006121. PubMed ID: 20556764
[TBL] [Abstract][Full Text] [Related]
38. Decision analysis of stereotactic radiation surgery versus stereotactic radiation surgery and whole-brain radiation therapy for 1 to 3 brain metastases.
Lester-Coll NH; Dosoretz AP; Yu JB
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):563-8. PubMed ID: 24751412
[TBL] [Abstract][Full Text] [Related]
39. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
[TBL] [Abstract][Full Text] [Related]
40. Validation of the Disease-Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC.
Woody NM; Greer MD; Reddy CA; Videtic GMM; Chao ST; Murphy ES; Suh JH; Angelov L; Barnett GH; Vogelbaum MA; Stephans KL
Clin Lung Cancer; 2018 Jan; 19(1):e141-e147. PubMed ID: 28739316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
